Nottingham Breast Pathology Masterclass Faculty (2017)
Professor Ian Ellis
Professor Emad Rakha
Professor Sarah Pinder
Professor Cecily Quinn
Dr Andrew HS Lee
Dr Abeer Shabaan
Dr Jeremy Thomas
Dr. Uma Krishnamurti
Professor Ian Ellis – Professor of Cancer Pathology, Division of Cancer and Stem Cells, School of Medicine, Nottingham University, Honorary Consultant Pathologist Nottingham City Hospital, founding member of the faculty of the Nottingham International Breast Education Centre. He has been Specialty Advisor of The Royal College of Pathologists, and is Chairman of the UK National Coordinating Committee for Breast Pathology. He has acted as an advisor to the Department of Health London, the Union for International Cancer Control, the World Health Organization and the International Agency for Research on Cancer. He is a founder of PathLore specialist pathology and reference laboratory, and Medical Director for Source Bioscience plc. Dr. Ellis has authored over 500 peer-reviewed scientific publications, and chapters in medical and pathology textbooks.
Professor Emad Rakha Professor and Honorary Consultant Pathologist Department of Histopathology, The University of Nottingham and Nottingham University Hospitals NHS Trust. Dr Rakha has authored over 230 peer-reviewed scientific publications, in addition to several chapters in medical and pathology textbooks in the field of breast disease. He is member of the National Co-ordinating Committee for Breast Pathology (BIG18), UK PathSoc Educational Committee, International society of Breast Pathology Committee, Breast Cancer Now Tissue bank Access Committee, Nottingham Health Science Biobank Board and The NCRI Breast CSG Translational Subgroup. Professor Rakha has been reporting breast referral cases in Nottingham since 2011 and he reports private breast cases referred to Source Biosciences plc.
Professor Sarah Pinder – Professor of Breast Pathology & Head of Research Oncology King’s College London and Lead Consultant Breast Pathologist at Guy’s and St Thomas’ Hospitals. She serves on the National Cancer Intelligence Network (NCIN) Breast Reference Group, the NHS Breast Screening Programme Pathology Co-ordinating Committee, the Sloane Project (UK National DCIS audit) Steering Group and Chairs the NHS Breast Screening Programme Pathology Research Committee. Professor Pinder has published approximately 200 peer-reviewed articles, over 50 invited reviews, and approximately 50 chapters on breast diseases in medical textbooks.
Professor Cecily Quinn – Consultant Histopathologist at St. Vincent’s University Hospital and Clinical Professor at UCD School of Medicine. She is Lead Histopathologist at the Merrion Unit of the Irish National Breast Screening Programme. She is also the RCPI National Specialty Director in Histopathology and represented histopathology on the RCPI Imrie and Keane review committees. Prof Quinn graduated from University College Galway in 1982. She trained at the Hammersmith Hospital and Royal Postgraduate Medical School in London and was Consultant Breast Histopathologist at The General Infirmary at Leeds and Honorary Senior Lecturer at the University of Leeds until 1999 when she took up her present post. Prof Quinn is a member of the Irish National Quality Assurance Breast Screening Committee and is the histopathology representative on the Breast Symptomatic Lead Clinicians Group. She attends the UK (NHS) Breast External Quality Assurance Committee and is Chair of the European Working Group for Breast Screening Pathology. Her main research interests are the pathology of early neoplastic lesions of the breast, and prognostic and predictive markers in invasive breast disease. She has 60 publications in peer-reviewed journals. She is a member of the HER2 and Triple Negative Research Group at St. Vincent’s University Hospital and the Translational Oncology Group at UCD. She is a member of the International Editorial Advisory Board of Histopathology and a committee member of the Pathological Society of Great Britain and Ireland.
Dr Andrew HS Lee – Consultant Histopathologist specialising in breast pathology at Nottingham University Hospitals. He has been a member of the National Coordinating Committee for Breast Pathology since 2006, chairing the group that organises the annual National Breast Pathology Update Courses. His research interests include core biopsy diagnosis, spindle cell and fibroepithelial lesions and prognostic factors in breast cancer including the role of inflammation.
Dr Jeremy Thomas – Consultant Pathologist in Edinburgh with active resercah interests in breast cancer, including i) Screen-detected ductal carcinoma in citu (DCIS) including diagnosis and staging. ii) Translational breast cancer research including pathology support for large clinical trials: Supremo, Artemis and Rosco. iii) Pathological evaluation of tissues following neoadjuvant chemotherapy. iv) Management of the axilla in breast cancer, and v) Quality assurance in breast cancer receptor testing. He is also a member of the Sloane Project Steering Group which has been studying UK screen-detected DCIS for the last ten years with a study cohort of over 12000 patients.http://www.breastpathology.info/
Dr Abeer Shaaban – Consultant Breast Pathologist/ Honorary Senior Lecturer Department of Cellular Pathology, Queen Elizabeth Hospital Birmingham. Dr Shaaban is a specialist breast pathologist and member of the International Committee of the Royal College of Pathologists and the Scientific Advisory Committee of Breast Cancer Campaign.
Dr. Uma Krishnamurti –Assistant Professor in the Department of Pathology & Laboratory Medicine at the Emory University School of Medicine. Dr. Krishnamurti is certified in cytopathology, and anatomic pathology & clinical pathology by the American Board of Pathology. Prior to joining Emory, she was a pathologist at Allegheny General Hospital in Pittsburgh, PA. She is a member of the Cancer Genetics and Epigenetics research program at Winship Cancer Institute.